Join us for the Midlands edition of the 2025 Fall Seminar Series: The GLP-1 Effect: Science, Strategy, and the Future of Workforce Wellbeing.
This luncheon features a cross-sector panel of experts exploring the evolving impact of GLP-1 medications on workforce health, chronic disease prevention, behavior change, and employee benefits strategy.
Panelists will share insights across four key dimensions:
- Clinical science and evidence, including how GLP-1s work and what the latest research shows
- Behavioral health and lifestyle change, including mental health implications and long-term motivation
- Employer strategy, from coverage decisions and culture to stigma and employee engagement
- Cost, access, and equity, including payer considerations and long-term outcomes
Attendees will enjoy a healthy, delicious lunch and an opportunity to network and connect with fellow SCHBC members, exhibitors, and sponsors—alongside a timely, expert-led panel discussion with practical takeaways for today’s workplace leaders.
This event is free to attend, but space is limited. Please RSVP to confirm your participation.
